Israel Englander Castle Biosciences Inc Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Castle Biosciences Inc stock. As of the latest transaction made, Millennium Management LLC holds 140,537 shares of CSTL stock, worth $3.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

140,537

Previous 460,000 69.45%

Holding current value

$3.75 Million

Previous $10 Million 59.98%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.4 - $31.47 $1.84 Million - $3.33 Million	105,710 Added 303.53%	140,537 $4.01 Million
Q2 2024 Aug 14, 2024	SELL	$18.84 - $24.94 $4.03 Million - $5.33 Million	-213,726 Reduced 85.99%	34,827 $758,000
Q1 2024 May 15, 2024	SELL	$18.06 - $25.3 $8.45 Million - $11.8 Million	-467,797 Reduced 65.3%	248,553 $5.51 Million
Q4 2023 Feb 14, 2024	SELL	$12.19 - $22.43 $3.89 Million - $7.16 Million	-319,243 Reduced 30.83%	716,350 $15.5 Million
Q2 2023 Aug 14, 2023	BUY	$11.66 - $26.0 $2.45 Million - $5.46 Million	210,156 Added 25.46%	1,035,593 $14.2 Million
Q1 2023 May 15, 2023	SELL	$19.47 - $28.49 $1.71 Million - $2.51 Million	-87,938 Reduced 9.63%	825,437 $18.8 Million
Q4 2022 Feb 14, 2023	SELL	$18.08 - $30.0 $885,305 - $1.47 Million	-48,966 Reduced 5.09%	913,375 $21.5 Million
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $1.36 Million - $2.07 Million	60,252 Added 6.68%	962,341 $25.1 Million
Q2 2022 Aug 15, 2022	BUY	$16.0 - $45.99 $10.1 Million - $28.9 Million	629,448 Added 230.87%	902,089 $19.8 Million
Q1 2022 May 16, 2022	SELL	$33.17 - $46.98 $8.09 Million - $11.5 Million	-243,865 Reduced 47.21%	272,641 $12.2 Million
Q4 2021 Feb 14, 2022	BUY	$39.06 - $67.58 $4.42 Million - $7.65 Million	113,147 Added 28.05%	516,506 $22.1 Million
Q3 2021 Nov 15, 2021	BUY	$60.13 - $77.6 $24.3 Million - $31.3 Million	403,359 New	403,359 $26.8 Million
Q2 2021 Aug 16, 2021	SELL	$50.07 - $76.78 $12.5 Million - $19.2 Million	-250,070 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$58.92 - $97.33 $13.7 Million - $22.7 Million	-233,209 Reduced 48.26%	250,070 $17.1 Million
Q4 2020 Feb 16, 2021	BUY	$43.6 - $73.05 $5.6 Million - $9.39 Million	128,548 Added 36.24%	483,279 $32.5 Million
Q3 2020 Nov 16, 2020	BUY	$38.47 - $52.03 $261,711 - $353,960	6,803 Added 1.96%	354,731 $18.3 Million
Q2 2020 Aug 14, 2020	BUY	$27.28 - $43.01 $3.78 Million - $5.96 Million	138,479 Added 66.12%	347,928 $13.1 Million
Q1 2020 May 14, 2020	BUY	$23.08 - $35.53 $4.83 Million - $7.44 Million	209,449 New	209,449 $6.24 Million
Q4 2019 Feb 14, 2020	SELL	$15.74 - $35.04 $2.45 Million - $5.45 Million	-155,538 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$18.09 - $27.92 $2.81 Million - $4.34 Million	155,538 New	155,538 $2.81 Million

Others Institutions Holding CSTL

# of Institutions

201

Shares Held

24.5M

Call Options Held

303K

Put Options Held

30.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $701M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account